Literature DB >> 17106335

Quality of life of cancer survivors after physical and psychosocial rehabilitation.

Irene Korstjens1, Ilse Mesters, Evelien van der Peet, Brigitte Gijsen, Bart van den Borne.   

Abstract

As the number of newly diagnosed cancer patients and the survival rates of cancer increase, more and more cancer patients are facing distressing physical and psychosocial problems as a result of their cancer and its treatment. To address these problems, a 12-week rehabilitation group program for cancer patients (all cancer types), combining physical exercise and psycho-education, was tested in a longitudinal cohort study (n=658). At baseline, participants reported a low quality of life, measured by the European Organization for Research and Treatment of Cancer (EORTC) Quality of Life Questionnaire (QLQ-C30) (range 0-100). Halfway through the intervention significant improvements were found in all domains, except cognitive functioning. At the end of rehabilitation, participants had reached significant improvements on all outcome variables: in global quality of life (from 63.0 to 71.9), emotional functioning (from 66.2 to 74.4), cognitive functioning (from 70.5 to 74.4) and fatigue level (reduction from 49.8 to 41.8) while, moreover, non-breast cancer patients showed clinically relevant improvement in physical functioning (from 67.3 to 80.4) and social functioning (from 63.4 to 79.4) and non-working patients showed a clinically relevant improvement in role functioning (from 57.0 to 69.6).

Entities:  

Mesh:

Year:  2006        PMID: 17106335     DOI: 10.1097/01.cej.0000220625.77857.95

Source DB:  PubMed          Journal:  Eur J Cancer Prev        ISSN: 0959-8278            Impact factor:   2.497


  15 in total

1.  Meeting the Challenges of Intervention Research in Health Science: An Argument for a Multimethod Research Approach.

Authors:  Helle Ploug Hansen; Tine Tjørnhøj-Thomsen
Journal:  Patient       Date:  2016-06       Impact factor: 3.883

2.  Potential factors associated with perceived cognitive impairment in breast cancer survivors.

Authors:  Jamie S Myers; Jo A Wick; Jennifer Klemp
Journal:  Support Care Cancer       Date:  2015-04-03       Impact factor: 3.603

Review 3.  Home-based multidimensional survivorship programmes for breast cancer survivors.

Authors:  Karis Kin Fong Cheng; Yee Ting Ethel Lim; Zhi Min Koh; Wilson Wai San Tam
Journal:  Cochrane Database Syst Rev       Date:  2017-08-24

4.  An interprofessional palliative care oncology rehabilitation program: effects on function and predictors of program completion.

Authors:  M R Chasen; A Feldstain; D Gravelle; N Macdonald; J Pereira
Journal:  Curr Oncol       Date:  2013-12       Impact factor: 3.677

Review 5.  Exploration of return-to-work interventions for breast cancer patients: a scoping review.

Authors:  Karine Bilodeau; Dominique Tremblay; Marie-José Durand
Journal:  Support Care Cancer       Date:  2017-01-04       Impact factor: 3.603

6.  Effects of BEAT Cancer randomized physical activity trial on subjective memory impairments in breast cancer survivors.

Authors:  Diane K Ehlers; Laura Q Rogers; Kerry S Courneya; Randall S Robbs; Edward McAuley
Journal:  Psychooncology       Date:  2017-05-11       Impact factor: 3.894

Review 7.  Physical activity.

Authors:  Anna L Schwartz
Journal:  Semin Oncol Nurs       Date:  2008-08       Impact factor: 2.315

Review 8.  Effectiveness of multidimensional cancer survivor rehabilitation and cost-effectiveness of cancer rehabilitation in general: a systematic review.

Authors:  Janne C Mewes; Lotte M G Steuten; Maarten J Ijzerman; Wim H van Harten
Journal:  Oncologist       Date:  2012-09-14

Review 9.  Exercise as an Intervention to Mitigate Decreased Cognitive Function From Cancer and Cancer Treatment: An Integrative Review.

Authors:  Jamie S Myers; Kirk I Erickson; Susan M Sereika; Catherine M Bender
Journal:  Cancer Nurs       Date:  2018 Jul/Aug       Impact factor: 2.592

Review 10.  Return to work of breast cancer survivors: a systematic review of intervention studies.

Authors:  J L Hoving; M L A Broekhuizen; M H W Frings-Dresen
Journal:  BMC Cancer       Date:  2009-04-21       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.